Albert Quoc-Hoa Lam, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pluripotent Stem Cells | 5 | 2015 | 794 | 1.020 |
Why?
|
| Nephrons | 2 | 2015 | 168 | 0.560 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 382 | 0.390 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2012 | 155 | 0.360 |
Why?
|
| Mesoderm | 1 | 2013 | 673 | 0.360 |
Why?
|
| Cell Differentiation | 5 | 2015 | 11512 | 0.320 |
Why?
|
| Nephrology | 1 | 2012 | 263 | 0.310 |
Why?
|
| Kidney Diseases | 3 | 2016 | 2092 | 0.260 |
Why?
|
| Regeneration | 1 | 2015 | 1505 | 0.260 |
Why?
|
| Proteinuria | 1 | 2008 | 605 | 0.240 |
Why?
|
| Kidney | 3 | 2015 | 7033 | 0.240 |
Why?
|
| Bone Diseases | 1 | 2008 | 418 | 0.230 |
Why?
|
| Embryonic Stem Cells | 3 | 2015 | 1246 | 0.220 |
Why?
|
| Medical Oncology | 1 | 2012 | 2320 | 0.180 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1923 | 0.170 |
Why?
|
| Organoids | 2 | 2015 | 744 | 0.160 |
Why?
|
| Anemia | 1 | 2008 | 1504 | 0.150 |
Why?
|
| Glomerulonephritis, Membranous | 2 | 2016 | 87 | 0.140 |
Why?
|
| Paraproteins | 1 | 2016 | 38 | 0.140 |
Why?
|
| Germ Layers | 1 | 2015 | 71 | 0.120 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2014 | 33 | 0.120 |
Why?
|
| Complement C4b | 1 | 2014 | 125 | 0.120 |
Why?
|
| Foreskin | 1 | 2013 | 33 | 0.110 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 567 | 0.110 |
Why?
|
| Paraproteinemias | 1 | 2016 | 250 | 0.110 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2013 | 31 | 0.110 |
Why?
|
| PAX2 Transcription Factor | 1 | 2013 | 86 | 0.110 |
Why?
|
| TRPP Cation Channels | 1 | 2013 | 177 | 0.100 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 167 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2014 | 1852 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 412 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2013 | 588 | 0.100 |
Why?
|
| Tretinoin | 1 | 2013 | 517 | 0.090 |
Why?
|
| HLA Antigens | 1 | 2014 | 1331 | 0.080 |
Why?
|
| Amyloidosis | 1 | 2016 | 865 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 931 | 0.070 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2004 | 33 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2014 | 1866 | 0.060 |
Why?
|
| Neoplasms | 1 | 2012 | 22142 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2013 | 4138 | 0.050 |
Why?
|
| Cell Line | 2 | 2013 | 15545 | 0.050 |
Why?
|
| Models, Biological | 2 | 2015 | 9458 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5103 | 0.050 |
Why?
|
| Pyridines | 1 | 2013 | 2872 | 0.050 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 3025 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 3027 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2012 | 2515 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2013 | 2802 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 13632 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 754 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2008 | 2770 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 81330 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cryoglobulinemia | 1 | 2016 | 84 | 0.030 |
Why?
|
| Humans | 11 | 2016 | 761222 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2016 | 286 | 0.030 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2016 | 123 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2426 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2015 | 315 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 289 | 0.030 |
Why?
|
| Glomerulonephritis | 1 | 2016 | 333 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 12101 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2016 | 646 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 4537 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2008 | 9319 | 0.030 |
Why?
|
| Animals | 3 | 2014 | 168089 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 801 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 8002 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 29893 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 29688 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 1216 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 13511 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 23419 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1662 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 13367 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 74241 | 0.020 |
Why?
|
| Janus Kinase 3 | 1 | 2004 | 77 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 1129 | 0.010 |
Why?
|
| Male | 3 | 2014 | 360703 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2015 | 3434 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12976 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 3073 | 0.010 |
Why?
|
| Female | 2 | 2013 | 392552 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3778 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5666 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22174 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26200 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39127 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 221120 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 39957 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 220858 | 0.000 |
Why?
|